Image Credit: Epia Neuro
Epia Neuro is a San Francisco brain-computer interface company that came out of stealth in early April 2026. It is focused on restoring function for people with neurological conditions, starting with post-stroke motor impairment and later expanding to areas such as cognitive decline and other neurologic disorders. The company describe it as building “intent-driven” neurotechnology that translates brain signals into action. Their leadership team includes Michel Maharbiz, PhD as CEO, Gil Mandelbaum, PhD as Chief Technology and Science Officer, and Michelle Patruno as COO.
Epia’s first product is a dual-phase stroke therapy intended to support both rehabilitation after stroke and long-term assistive living. The platform combines:
- an implantable brain interface,
- a decoder/AI layer that interprets neural signals, and
- an external grip-assist motorized glove/prosthetic to help the user open and close the hand.